期刊
CELL DEATH & DISEASE
卷 11, 期 8, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41419-020-02885-0
关键词
-
类别
资金
- Science and Technology Program of Guangzhou, China [201704020216]
- Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110105014]
- Guangdong Provincial Department of Education High-level University Construction Funding Southern Medical University Clinical Research Startup Program [LC2016ZD027]
- Natural Science Foundation of Guangdong Province, China [2018B030311042]
- Science and Technology Planning Project of Guangdong Province, China [2017A020215043, 2017A020215183]
Utilizing oxidative stress has recently been regarded as a potential strategy for tumor therapy. The NUAK family SNF1-like kinase 1 (NUAK1) is a critical component of the antioxidant defense system and is necessary for the survival of tumors. Therefore, NUAK1 is considered an attractive therapeutic target in cancer. However, antioxidant therapy induced elevated ROS levels to activate the Unc-51-like kinase 1 (ULK1) pathway to promote protective autophagy and ULK1-dependent mitophagy. Thus, the combined inhibition of NUAK1 and ULK1 showed a strong synergistic effect in different tumor types. Herein, the potential antitumor activities of a dual NUAK1/ULK1 inhibitor MRT68921 were evaluated in both tumor cell lines and animal models. MRT68921 significantly kills tumor cells by breaking the balance of oxidative stress signals. These results highlight the potential of MRT68921 as an effective agent for tumor therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据